These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 12124323

  • 1. Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method.
    Iizuka N, Oka M, Yamada-Okabe H, Mori N, Tamesa T, Okada T, Takemoto N, Tangoku A, Hamada K, Nakayama H, Miyamoto T, Uchimura S, Hamamoto Y.
    Cancer Res; 2002 Jul 15; 62(14):3939-44. PubMed ID: 12124323
    [Abstract] [Full Text] [Related]

  • 2. Molecular signature in three types of hepatocellular carcinoma with different viral origin by oligonucleotide microarray.
    Iizuka N, Oka M, Yamada-Okabe H, Hamada K, Nakayama H, Mori N, Tamesa T, Okada T, Takemoto N, Matoba K, Takashima M, Sakamoto K, Tangoku A, Miyamoto T, Uchimura S, Hamamoto Y.
    Int J Oncol; 2004 Mar 15; 24(3):565-74. PubMed ID: 14767541
    [Abstract] [Full Text] [Related]

  • 3. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
    Zondervan PE, Wink J, Alers JC, IJzermans JN, Schalm SW, de Man RA, van Dekken H.
    J Pathol; 2000 Oct 15; 192(2):207-15. PubMed ID: 11004697
    [Abstract] [Full Text] [Related]

  • 4. Differential gene expression in distinct virologic types of hepatocellular carcinoma: association with liver cirrhosis.
    Iizuka N, Oka M, Yamada-Okabe H, Mori N, Tamesa T, Okada T, Takemoto N, Hashimoto K, Tangoku A, Hamada K, Nakayama H, Miyamoto T, Uchimura S, Hamamoto Y.
    Oncogene; 2003 May 15; 22(19):3007-14. PubMed ID: 12771952
    [Abstract] [Full Text] [Related]

  • 5. Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas.
    Kim MY, Park E, Park JH, Park DH, Moon WS, Cho BH, Shin HS, Kim DG.
    Oncogene; 2001 Jul 27; 20(33):4568-75. PubMed ID: 11494152
    [Abstract] [Full Text] [Related]

  • 6. Different expression of hepatitis B surface antigen between hepatocellular carcinoma and its surrounding liver tissue, studied using a tissue microarray.
    Wang Y, Wu MC, Sham JS, Tai LS, Fang Y, Wu WQ, Xie D, Guan XY.
    J Pathol; 2002 Aug 27; 197(5):610-6. PubMed ID: 12210080
    [Abstract] [Full Text] [Related]

  • 7. Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.
    Okamoto M, Utsunomiya T, Wakiyama S, Hashimoto M, Fukuzawa K, Ezaki T, Hanai T, Inoue H, Mori M.
    Ann Surg Oncol; 2006 Jul 27; 13(7):947-54. PubMed ID: 16788756
    [Abstract] [Full Text] [Related]

  • 8. Distinctive gene expression profiles associated with Hepatitis B virus x protein.
    Wu CG, Salvay DM, Forgues M, Valerie K, Farnsworth J, Markin RS, Wang XW.
    Oncogene; 2001 Jun 21; 20(28):3674-82. PubMed ID: 11439330
    [Abstract] [Full Text] [Related]

  • 9. Identification of ID2 associated with invasion of hepatitis C virus-related hepatocellular carcinoma by gene expression profile.
    Tsunedomi R, Iizuka N, Yamada-Okabe H, Tamesa T, Okada T, Sakamoto K, Takashima M, Hamaguchi T, Miyamoto T, Uchimura S, Hamamoto Y, Yamada M, Oka M.
    Int J Oncol; 2006 Dec 21; 29(6):1445-51. PubMed ID: 17088983
    [Abstract] [Full Text] [Related]

  • 10. Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags.
    Yoon SY, Kim JM, Oh JH, Jeon YJ, Lee DS, Kim JH, Choi JY, Ahn BM, Kim S, Yoo HS, Kim YS, Kim NS.
    Int J Oncol; 2006 Aug 21; 29(2):315-27. PubMed ID: 16820872
    [Abstract] [Full Text] [Related]

  • 11. Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4.
    Zekri AR, Bahnassy AA, Abdel-Wahab SA, Khafagy MM, Loutfy SA, Radwan H, Shaarawy SM.
    J Gastroenterol Hepatol; 2009 Mar 21; 24(3):416-28. PubMed ID: 19054267
    [Abstract] [Full Text] [Related]

  • 12. Marked genetic similarities between hepatitis B virus-positive and hepatitis C virus-positive hepatocellular carcinomas.
    Tornillo L, Carafa V, Richter J, Sauter G, Moch H, Minola E, Gambacorta M, Bianchi L, Vecchione R, Terracciano LM.
    J Pathol; 2000 Nov 21; 192(3):307-12. PubMed ID: 11054713
    [Abstract] [Full Text] [Related]

  • 13. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
    Marotta F, Vangieri B, Cecere A, Gattoni A.
    Clin Ter; 2004 May 21; 155(5):187-99. PubMed ID: 15344567
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1.
    Wong QW, Lung RW, Law PT, Lai PB, Chan KY, To KF, Wong N.
    Gastroenterology; 2008 Jul 21; 135(1):257-69. PubMed ID: 18555017
    [Abstract] [Full Text] [Related]

  • 15. Parallel epigenetic and genetic changes in the pathogenesis of hepatitis virus-associated hepatocellular carcinoma.
    Feitelson MA.
    Cancer Lett; 2006 Jul 28; 239(1):10-20. PubMed ID: 16154256
    [Abstract] [Full Text] [Related]

  • 16. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area.
    Huang YH, Wu JC, Chen CH, Chang TT, Lee PC, Chau GY, Lui WY, Chang FY, Lee SD.
    Liver Int; 2005 Apr 28; 25(2):236-41. PubMed ID: 15780044
    [Abstract] [Full Text] [Related]

  • 17. Sequencing of human-viral DNA junctions in hepatocellular carcinoma from patients with HCV and occult HBV infection.
    Tamori A, Nishiguchi S, Kubo S, Enomoto M, Koh N, Takeda T, Shiomi S, Hirohashi K, Kinoshita H, Otani S.
    J Med Virol; 2003 Apr 28; 69(4):475-81. PubMed ID: 12601754
    [Abstract] [Full Text] [Related]

  • 18. Molecular targets for therapy of hepatitis B virus-induced hepatocellular carcinoma.
    Tharayil VS, Roberts LR.
    Minerva Gastroenterol Dietol; 2006 Dec 28; 52(4):387-406. PubMed ID: 17108869
    [Abstract] [Full Text] [Related]

  • 19. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
    Tamori A, Nishiguchi S, Kubo S, Narimatsu T, Habu D, Takeda T, Hirohashi K, Shiomi S.
    J Med Virol; 2003 Dec 28; 71(4):492-8. PubMed ID: 14556260
    [Abstract] [Full Text] [Related]

  • 20. Preneoplastic markers of hepatitis B virus-associated hepatocellular carcinoma.
    Hann HW, Lee J, Bussard A, Liu C, Jin YR, Guha K, Clayton MM, Ardlie K, Pellini MJ, Feitelson MA.
    Cancer Res; 2004 Oct 15; 64(20):7329-35. PubMed ID: 15492253
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.